Preface |
|
7 | (1) |
|
Part 1 Basic physiology and practice |
|
|
|
Haemopoiesis: physiology and pathology |
|
|
8 | (2) |
|
Normal blood cells I: red cells |
|
|
10 | (2) |
|
Normal blood cells II: granulocytes, monocytes and the reticuloendothelial system |
|
|
12 | (2) |
|
Normal blood cells III: lymphocytes |
|
|
14 | (2) |
|
Lymph nodes, the lymphatic system and the spleen |
|
|
16 | (2) |
|
|
18 | (2) |
|
|
20 | (2) |
|
|
22 | (2) |
|
Benign disorders of white cells: granulocytes, monocytes, macrophages and lymphocytes |
|
|
24 | (2) |
|
Part 2 Red cell disorders |
|
|
|
General aspects of red cells |
|
|
26 | (2) |
|
Iron I: physiology and deficiency |
|
|
28 | (2) |
|
Iron II: overload and sideroblastic anaemia |
|
|
30 | (2) |
|
Megaloblastic anaemia I: vitamin B12 and folic acid deficiency - biochemical basis, causes |
|
|
32 | (2) |
|
Megaloblastic anaemia II: clinical features, treatment and other macrocytic anaemias |
|
|
34 | (2) |
|
Haemolytic anaemias I: general |
|
|
36 | (2) |
|
Haemolytic anaemias II: inherited membrane and enzyme defects |
|
|
38 | (2) |
|
Haemolytic anaemias III: acquired |
|
|
40 | (2) |
|
Haemolytic anaemias IV: genetic defects of haemoglobin - thalassaemia |
|
|
42 | (2) |
|
Haemolytic anaemias V: genetic defects of haemoglobin - sickle cell disease |
|
|
44 | (2) |
|
Part 3 White cell disorders - myeloid |
|
|
|
|
46 | (2) |
|
Haematological malignancy: basic mechanisms |
|
|
48 | (2) |
|
Acute leukaemia I: classification and diagnosis |
|
|
50 | (3) |
|
Acute leukaemia II: treatment and prognosis |
|
|
53 | (1) |
|
Chronic myeloid leukaemia |
|
|
54 | (2) |
|
|
56 | (2) |
|
Myeloproliferative disorders I: introduction |
|
|
58 | (2) |
|
Myeloproliferative disorders II: polycythaemia rubra vera |
|
|
60 | (2) |
|
Myeloproliferative disorders III: essential thrombocythaemia and myelofibrosis |
|
|
62 | (2) |
|
Part 4 White cell disorders - lymphoid |
|
|
|
Chronic lymphocytic leukaemia |
|
|
64 | (2) |
|
|
66 | (2) |
|
Lymphoma I: Hodgkin lymphoma (Hodgkin's disease) |
|
|
68 | (2) |
|
Lymphoma II: Non-Hodgkin lymphoma - aetiology and classification |
|
|
70 | (2) |
|
Lymphoma III: Non-Hodgkin lymphoma - clinical and laboratory features of commoner subtypes |
|
|
72 | (2) |
|
Lymphoma IV: Non-Hodgkin lymphoma - treatment and prognosis |
|
|
74 | (2) |
|
Part 5 Clotting and platelet disorders |
|
|
|
Normal haemostasis I: vessel wall and platelets |
|
|
76 | (2) |
|
Normal haemostasis II: coagulation factors and fibrinolysis |
|
|
78 | (2) |
|
Disorders of haemostasis I: vessel wall and platelets |
|
|
80 | (2) |
|
Disorders of haemostasis II: inherited disorders of coagulation |
|
|
82 | (2) |
|
Disorders of haemostasis III: acquired disorders of coagulation |
|
|
84 | (2) |
|
Thrombosis and thrombophilia |
|
|
86 | (2) |
|
|
88 | (2) |
|
Part 6 Systemic conditions |
|
|
|
Haematological aspects of systemic disease I: inflammation - malignancy |
|
|
90 | (2) |
|
Haematological aspects of systemic disease II: renal, liver, endocrine, amyloid |
|
|
92 | (2) |
|
Haematological aspects of systemic disease III: infection |
|
|
94 | (2) |
|
Haematology of pregnancy and infancy |
|
|
96 | (2) |
|
Part 7 Treatment and procedures |
|
|
|
|
98 | (2) |
|
|
100 | (2) |
|
Stem cell transplantation |
|
|
102 | (2) |
|
General aspects of treatment |
|
|
104 | (2) |
|
Haematological effects of drugs |
|
|
106 | (2) |
|
|
|
|
108 | (2) |
|
Case studies and questions |
|
|
110 | (2) |
|
|
112 | (2) |
|
|
114 | (9) |
|
|
|
|
119 | (1) |
|
|
120 | (1) |
|
Cluster of differentiation nomenclature system |
|
|
121 | (1) |
|
|
122 | (1) |
Index |
|
123 | |